BDSX

0.882

4.22% -0.0389

Handel nachbörslich: .88 -0.002 -0.23%

Biodesix Inc (BDSX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.9209

Offen:

$0.92

24-Stunden-Volumen:

241.86K

Relative Volume:

0.51

Marktkapitalisierung:

$128.30M

Einnahmen:

$49.09M

Nettoeinkommen (Verlust:

$-52.15M

KGV:

-1.3569

EPS:

-0.65

Netto-Cashflow:

$-45.93M

1W Leistung:

-10.46%

1M Leistung:

-17.57%

6M Leistung:

-50.45%

1J Leistung:

-39.59%

1-Tages-Spanne:

$0.875

$0.9686

1-Wochen-Bereich:

$0.875

$1.02

52-Wochen-Spanne:

$0.8568

$2.04

Biodesix Inc Stock (BDSX) Company Profile

Firmenname

Biodesix Inc

Sektor

Healthcare (1169)

Branche

Diagnostics & Research (60)

Telefon

303-417-0500

Adresse

919 WEST DILLON ROAD, LOUISVILLE

Mitarbeiter

217

Twitter

Nächster Verdiensttermin

2024-11-27

Neueste SEC-Einreichungen

BDSX's Discussions on Twitter

Vergleichen Sie BDSX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BDSX Biodesix Inc	0.882	128.30M	49.09M	-52.15M	-45.93M	-0.65
TMO Thermo Fisher Scientific Inc	532.55	203.70B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	210.23	151.18B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	135.37	38.62B	6.51B	1.29B	1.37B	4.42
IDXX Idexx Laboratories Inc	452.77	37.07B	3.90B	887.87M	808.08M	10.67
IQV Iqvia Holdings Inc	191.04	33.64B	15.41B	1.37B	2.11B	7.50

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-09-16	Eingeleitet	Scotiabank	Sector Outperform
2024-07-26	Eingeleitet	Craig Hallum	Buy
2024-05-13	Eingeleitet	TD Cowen	Buy
2024-05-03	Eingeleitet	Lake Street	Buy
2021-11-17	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-11-23	Eingeleitet	BTIG Research	Buy
2020-11-23	Eingeleitet	Canaccord Genuity	Buy
2020-11-23	Eingeleitet	Morgan Stanley	Overweight
2020-11-23	Eingeleitet	William Blair	Outperform

Alle ansehen

Biodesix Inc Aktie (BDSX) Neueste Nachrichten

Feb 18, 2025

Biodesix, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - Nasdaq

Feb 18, 2025

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewswire

Feb 18, 2025

Feb 17, 2025

Insider Selling: Biodesix, Inc. (NASDAQ:BDSX) CEO Sells 83,660 Shares of Stock - MarketBeat

Feb 17, 2025

Biodesix, Inc. (NASDAQ:BDSX) Insider Gary Anthony Pestano Sells 16,748 Shares - MarketBeat

Feb 17, 2025

Biodesix, Inc. (NASDAQ:BDSX) CFO Robin Harper Cowie Sells 24,664 Shares - MarketBeat

Feb 17, 2025

Feb 16, 2025

Stephens Inc. AR Makes New $303,000 Investment in Biodesix, Inc. (NASDAQ:BDSX) - Defense World

Feb 16, 2025

Feb 15, 2025

Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock By Investing.com - Investing.com Australia

Feb 12, 2025

Biodesix CEO Scott Hutton sells shares worth $77,318 By Investing.com - Investing.com Australia

Feb 12, 2025

Biodesix chief commercial officer sells shares worth $16,198 By Investing.com - Investing.com Australia

Feb 12, 2025

Biodesix CFO sells $22,794 in stock By Investing.com - Investing.com Australia

Feb 12, 2025

BIODESIX Executives Sell Shares to Cover Taxes - TradingView

Feb 12, 2025

Feb 06, 2025